Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele.
Hoffman JD, Bianchi DW, Sullivan LM, Mackinnon BL, Collins J, Malone FD, Porter TF, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. Hoffman JD, et al. Among authors: carr sr. Prenat Diagn. 2008 Dec;28(13):1204-8. doi: 10.1002/pd.2082. Prenat Diagn. 2008. PMID: 19034930 Free PMC article.
First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. Malone FD, et al. Among authors: carr sr. N Engl J Med. 2005 Nov 10;353(19):2001-11. doi: 10.1056/NEJMoa043693. N Engl J Med. 2005. PMID: 16282175 Free article. Clinical Trial.
Comparison of serum markers in first-trimester down syndrome screening.
Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME; First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. Canick JA, et al. Among authors: carr sr. Obstet Gynecol. 2006 Nov;108(5):1192-9. doi: 10.1097/01.AOG.0000241095.19638.f2. Obstet Gynecol. 2006. PMID: 17077242
Contingent screening for Down syndrome--results from the FaSTER trial.
Cuckle HS, Malone FD, Wright D, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Ferreira JC, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, D'Alton ME. Cuckle HS, et al. Among authors: carr sr. Prenat Diagn. 2008 Feb;28(2):89-94. doi: 10.1002/pd.1913. Prenat Diagn. 2008. PMID: 18236423
Role of second-trimester genetic sonography after Down syndrome screening.
Aagaard-Tillery KM, Malone FD, Nyberg DA, Porter TF, Cuckle HS, Fuchs K, Sullivan L, Comstock CH, Saade GR, Eddleman K, Gross S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Bianchi DW, D'Alton ME; First and Second Trimester Evaluation of Risk (FASTER) Research Consortium. Aagaard-Tillery KM, et al. Among authors: carr sr. Obstet Gynecol. 2009 Dec;114(6):1189-1196. doi: 10.1097/AOG.0b013e3181c15064. Obstet Gynecol. 2009. PMID: 19935018 Free PMC article. Clinical Trial.
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidaver J, D'Alton ME. Dugoff L, et al. Among authors: carr sr. Am J Obstet Gynecol. 2004 Oct;191(4):1446-51. doi: 10.1016/j.ajog.2004.06.052. Am J Obstet Gynecol. 2004. PMID: 15507981
Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers.
Dugoff L, Cuckle HS, Hobbins JC, Malone FD, Belfort MA, Nyberg DA, Comstock CH, Saade GR, Eddleman KA, Dar P, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME; FaSTER Trial Research Consortium. Dugoff L, et al. Among authors: carr sr. Am J Obstet Gynecol. 2008 Sep;199(3):290.e1-6. doi: 10.1016/j.ajog.2008.06.099. Am J Obstet Gynecol. 2008. PMID: 18771987
Quad screen as a predictor of adverse pregnancy outcome.
Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, Lambert-Messerlian GM, Porter TF, Luthy DA, Comstock CH, Saade G, Eddleman K, Merkatz IR, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME; FASTER Trial Research Consortium. Dugoff L, et al. Among authors: carr sr. Obstet Gynecol. 2005 Aug;106(2):260-7. doi: 10.1097/01.AOG.0000172419.37410.eb. Obstet Gynecol. 2005. PMID: 16055573
Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
Comstock CH, Malone FD, Ball RH, Nyberg DA, Saade GR, Berkowitz RL, Ferreira J, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Bianchi DW, D'Alton ME; FASTER Research Consortium. Comstock CH, et al. Among authors: carr sr. Am J Obstet Gynecol. 2006 Sep;195(3):843-7. doi: 10.1016/j.ajog.2006.06.006. Am J Obstet Gynecol. 2006. PMID: 16949423
Nuchal translucency and the risk of congenital heart disease.
Simpson LL, Malone FD, Bianchi DW, Ball RH, Nyberg DA, Comstock CH, Saade G, Eddleman K, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, D'Alton ME. Simpson LL, et al. Among authors: carr sr. Obstet Gynecol. 2007 Feb;109(2 Pt 1):376-83. doi: 10.1097/01.AOG.0000250473.99575.72. Obstet Gynecol. 2007. PMID: 17267839
130 results